PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsE7389
E7389
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
250 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50329745425186
Male breast neoplasmsD018567———1—1—2
Drug-related side effects and adverse reactionsD064420—T88.7———1—1
Neurotoxicity syndromesD020258—G92———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Triple negative breast neoplasmsD064726——112615—453
NeoplasmsD009369—C8031101——35
CarcinomaD002277—C80.01082——16
SarcomaD012509——682—114
RecurrenceD012008——571—112
Neoplasm metastasisD009362EFO_0009708—263——10
Brain neoplasmsD001932EFO_0003833C71242——7
Non-small-cell lung carcinomaD002289——341——7
Transitional cell carcinomaD002295——241——6
Lung neoplasmsD008175—C34.90231——5
Show 9 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ovarian neoplasmsD010051EFO_0003893C5641———5
Ovarian epithelial carcinomaD000077216——41———5
Prostatic neoplasmsD011471—C6122———4
LiposarcomaD008080——23———4
Inflammatory breast neoplasmsD058922——13———3
MelanomaD008545——21——13
LeiomyosarcomaD007890——13———3
Urethral neoplasmsD014523EFO_0003846——2———2
Ureteral neoplasmsD014516EFO_0003844C66—2———2
Renal cell carcinomaD002292EFO_0000376—21———2
Show 31 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.92————2
Skin neoplasmsD012878EFO_0004198C441————1
Cutaneous malignant melanomaD000096142——1————1
Abdominal neoplasmsD000008——1————1
Retroperitoneal neoplasmsD012186——1————1
Renal insufficiencyD051437—N191————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Peripheral nervous system diseasesD010523—G64————22
Alopecia areataD000506EFO_0004192L63————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
195 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use